RiceBran operates a differentiated bio-refining model producing non-GMO, gluten-free ingredient products targeting premium and functional food segments. Following the sale of its stabilized rice bran (SRB) business to Stabil Nutrition in June 2023, the company refocused on grain milling and specialty ingredient processing, leveraging its acquired assets from MGI Grain (April 2019) to serve barley, oats, and mustard processing segments.
Cyborg Score Rationale
RiceBran operates in a niche but competitive specialty ingredient market with diversified product lines and proprietary technology. However, the company faces revenue concentration risk with limited significant customers, operates at modest scale (~$31M revenue as of December 2023), and executed a material asset sale in 2023 that signals strategic restructuring rather than growth acceleration.
Top Insights
Sold stabilized rice bran (SRB) business for ~$3.5M in June 2023 as first step of strategic review, indicating potential pivot from core business
Revenue reached $31M as of December 2023 with ~201 employees; company faces material customer concentration risk
Proprietary stabilization and derivative processing technology addresses non-GMO and organic market demand trends
Operates grain milling facility in Minnesota processing barley, oats, and mustard alongside rice bran ingredient production
Named Competitors
Great River Organic Milling — Organic grain milling and specialty ingredients
Alternative plant-based ingredients — Plant-based functional food alternatives
Recent Developments
(June 2023) Sold stabilized rice bran business to Stabil Nutrition for $3.5M in cash and lease assumption
(December 2023) Annual revenue reached $31M with 201 employees across North America and Asia
Open the full interactive RiceBran Technologies report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.